<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00694278</url>
  </required_header>
  <id_info>
    <org_study_id>LMC95</org_study_id>
    <nct_id>NCT00694278</nct_id>
  </id_info>
  <brief_title>Clinical Evaluation of the Effect of Duodenal-Jejunal Bypass on Type 2 Diabetes</brief_title>
  <official_title>Clinical Evaluation of the Effect of Duodenal-Jejunal Bypass on Type 2 Diabetes in Adults</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ferzli, George S., M.D. F.A.C.S.</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ferzli, George S., M.D. F.A.C.S.</source>
  <brief_summary>
    <textblock>
      The aim of this study and the primary outcome is to clinically evaluate effect of
      laparoscopic duodenal-jejunal bypass on non-obese type 2 diabetes. Secondary outcomes will
      evaluate CCK, FFA, Cholesterol Ghrelin, C-peptide, and HbA1c levels. Patients will be
      followed closely to ensure the desired results are sustained in long term
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>June 2008</start_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <enrollment type="Anticipated">15</enrollment>
  <condition>Type II Diabetes</condition>
  <eligibility>
    <study_pop>
      <textblock>
        primary care office
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adults age 20-65 years

          -  Clinical diagnosis of type II diabetes buy on of the following three criteria
             (American Diabetes Association)

               1. A normal or high C-peptide level (to exclude type 1 diabetes) (&gt;.9ng/ml)

               2. A random plasma glucose of 200mg/dl or more with typical symptom of diabetes

               3. A fasting plasma glucose of 126mg/dl or more on more than one occasion

          -  BMI 22-34 KG/m2

          -  Patients on oral hypoglycemic medications or insulin to control T2DM

          -  Inadequate control of diabetes as defined as HbA1c&gt;7.5

          -  No contraindication for surgery or General Anesthesia as determined by
             multidisciplinary surgical team

          -  Ability to understand and describe the mechanism of action of ricks and benefits of
             the operation

        Exclusion Criteria:

          -  Patients who meet any of the following exclusion criteria will be exclusion criteria
             will be excluded from enrollment into the study

          -  Enrolled in another clinical study which involves and investigational drug

          -  Diagnosis type 1 diabetes

          -  Pregnancy (all female patients will have beta HCG) or planned pregnancy within 2 years
             of entry into the study or unwilling to use reliable contraceptive method

          -  Previous gastric or esophageal surgery

          -  Immunosuppressive drugs including corticosteroids

          -  Coagulopathy (INR&gt;1.5 or platelets&lt;50,000/ul)

          -  Anemia (Hgb&lt;10.0g/dl)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>George Ferzli, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Lutheran Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>George Ferzli, MD</last_name>
    <phone>718-630-7351</phone>
    <email>gferzli@lmcmc.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Lutheran Medical Center</name>
      <address>
        <city>Brooklyn</city>
        <state>New York</state>
        <zip>11220</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>George Ferzli, MD</last_name>
      <phone>718-630-7351</phone>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 5, 2008</study_first_submitted>
  <study_first_submitted_qc>June 5, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 10, 2008</study_first_posted>
  <last_update_submitted>June 5, 2008</last_update_submitted>
  <last_update_submitted_qc>June 5, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 10, 2008</last_update_posted>
  <responsible_party>
    <name_title>Georger Ferzli M.D F.A.C.S.</name_title>
    <organization>Lutheran Medical Center</organization>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

